Tag Archives: Merck

Merck analysts to CEO: What’s so great about your pipeline beyond Keytruda?

Sales of Merck & Co.’s immuno-oncology heavy hitter Keytruda soared 66% in the fourth quarter to $ 2.15 billion, surpassing Wall Street’s expectations yet again. But Merck can’t rely solely on one blockbuster’s dutiful performance to drive sales and earnings growth going forward. Analysts’ worries about that fact only intensified on Friday after Merck put… Read More »

Solicitor general to back Merck at Supreme Court in Fosamax pre-emption case

Shortly after the U.S. Supreme Court agreed in June to hear Merck & Co.’s appeal in the years-long Fosamax liability litigation, acting Solicitor General Jefferey Wall asked for permission to present oral arguments. It would be a plus for Merck, because Wall has been a major voice on the hotly debated issue of pre-emption, which revolves around the question… Read More »